Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2025.Mar.10

The Company's Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting

2025.Feb.26

Announcement on behalf of Amaran’s BOD to resolve the reference date for conversion of employee stock options to common shares

2025.Feb.26

Announcement on behalf of Amaran that the BOD resolved to issue 2025 employee stock options and the subscription rules

2025.Feb.26

Announcement for the expected date of the Board of Directors Meeting for 2024 financial reports is 2025/03/10

2025.Feb.18

Announcement on behalf of OBIGEN Pharma the new appointment of CEO

2025.Feb.18

Announcement on behalf of OBIGEN Pharma of the BOD’s resolution to lift the non-competition restrictions for CEO

2025.Jan.22

Announcement on behalf of OBIGEN that TFDA clears OBI-858’s IND application for repeat-dose Phase II safety study

2025.Jan.03

OBI completed the capital reduction registration for the Restricted Stock Awards cancelled

2024.Dec.23

OBI Pharma and GlyTech have entered into a GlycOBI marketing agreement in Japan and a material transfer agreement

2024.Dec.10

Announcement on behalf of OBIGEN to acquire the worldwide intellectual property rights of OBI-858 and sign the technology transfer agreement

News

Latest News

Events

Latest events